+39 02 610346.1 - info@newron.com

Press Releases

Filter by year
  • august112020

    Newron Pharmaceuticals provides clinical and business update

     

  • may292020

    Newron Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

  • may42020

    Newron Reports Top-Line Results from its STARS Study Evaluating Sarizotan in Patients with Rett Syndrome

     

  • april292020

    Newron Acknowledges Definitive Agreement Between US WorldMeds and Supernus Pharmaceuticals Regarding XADAGO® (safinamide)

  • april152020

    Newron Receives Third Tranche from Financing Agreement with European Investment Bank (EIB)

     

  • march312020

    Newron AGM Result and Clinical and Business Update

     

  • march112020

    Newron updates on STARS study FDA interaction

     

  • march52020

    Newron announces 2019 financial results and provides outlook for 2020

     

  • february172020

    Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia

     

  • february42020

    Newron Pharmaceuticals to Present at the 22nd Annual BIO CEO & Investor Conference in New York

  • january92020

    Newron announces initiation of new clinical trial with Evenamide in patients with schizophrenia, following approval of plan by FDA